Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Freegold Intersects 3.62 g/t Au over 42m and 1.23 g/t Au over 170.7m (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Smith Nephew ADR Representing 2 Ord Shs C.SNN


Primary Symbol: SNN

Healthcare Medical Devices
Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. Its segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that help surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.


NYSE:SNN - Post by User

Smith Nephew ADR Representing 2 Ord Shs > New Canada campus construction video
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(121)
•••
Comment by JMark80on Jun 22, 2018 11:32am
117 Views
Post# 28213137

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:New Canada campus construction video

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:New Canada campus construction videoOf course I understand, are you sure you do? You were the one who said tenant agreements were akin to supply agreements which is completely wrong. They're mostly a middleman, they likely won't make anything on 70% of phase 1 production, only re-selling. Tell me why a company like Canndescent needs Sunniva? And yes, given their valuation they should own Cathedral, or at least have a CAPITAL lease. Greenhouse space in California for medical marijauna leases for $3 sq foot net per month. Owning would at least give them the ability to sublease and profit, while letting the tenants worry about distribution.

Are you sure you're not Sunniva4Life?
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities